These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6252598)

  • 1. Late results of preventive chemotherapy in persons with fibrotic lesions of the lung ; benefit, cost and risk (from the IUAT isoniazid prophylaxis trial).
    Krebs A; Claiciu I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1980; 29(2):77-82. PubMed ID: 6252598
    [No Abstract]   [Full Text] [Related]  

  • 2. The IUAT trial on isoniazid preventive treatment in persons with fibrotic lung lesions.
    Krebs A
    Bull Int Union Tuberc; 1976; 51(1):193-201. PubMed ID: 801115
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of preventive treatment with isoniazid in a high risk group. Results form an international Trial under the auspices of IUAT.
    Krebs A
    Scand J Respir Dis Suppl; 1978; 102():62-4. PubMed ID: 356260
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of preventive chemotherapy in the present tuberculosis epidemiology of GDR (author's transl)].
    Krebs A
    Z Erkr Atmungsorgane; 1977; 147(1):18-25. PubMed ID: 868133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perspective of tuberculosis control--role of preventive chemotherapy (author's transl)].
    Krebs A; Steinbrück P; Renger F; Weise L
    Z Erkr Atmungsorgane; 1979 Apr; 153(1):60-5. PubMed ID: 516804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The problem of preventive treatment with isoniazid in persons with fibrotic lesions in the lungs.
    Stýblo K; Danková D; Reil I; Krivánek J
    Scand J Respir Dis; 1968; 49(2):102-10. PubMed ID: 4972530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventive use of INH in patients with pulmonary fibrosis. Part II. Results of treatment. Discussion].
    Chwalibóg B
    Pneumonol Pol; 1980 Sep; 48(9):589-99. PubMed ID: 7001389
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preventive use of INH in patients with pulmonary fibrosis. Part I. Objectives, methods, material, patient acceptance and the tolerance of the treatment].
    Chwalibóg B
    Pneumonol Pol; 1980 Sep; 48(9):581-8. PubMed ID: 7001388
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive chemotherapy of intrapulmonary residual tuberculosis with isoniazid--example of failed compliance by the physician].
    Conen D; Zimmermann W; Dubach UC
    Schweiz Med Wochenschr; 1984 Aug; 114(34):1159-62. PubMed ID: 6484546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis risk in persons with "fibrotic" x-ray lesions.
    Steinbrück P; Dănkovã D; Edwards LB; Doster B; Livesay VT
    Bull Int Union Tuberc; 1972 Feb; 47():135-59. PubMed ID: 5077112
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The incidence rate of active pulmonary tuberculosis among adult population with fibrotic lesions].
    Shimouchi A; Ozasa K
    Kekkaku; 2003 Jan; 78(1):5-13. PubMed ID: 12655700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis.
    International Union Against Tuberculosis Committee on Prophylaxis
    Bull World Health Organ; 1982; 60(4):555-64. PubMed ID: 6754120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
    MacIntyre CR; Ansari MZ; Carnie J; Hart WG
    Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New data on preventive treatment with isoniazid.
    Comstock GW
    Ann Intern Med; 1983 May; 98(5 Pt 1):663-5. PubMed ID: 6342492
    [No Abstract]   [Full Text] [Related]  

  • 17. [The pro-fibrotic and pro-oxidant action of isoniazid].
    Andrzheiuk NI; Smirnova NA; Narovlianskaia SE; Novoselova VP; Kruglova EG
    Probl Tuberk; 1990; (8):7-11. PubMed ID: 2255708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults.
    Veening GJ
    Bull Int Union Tuberc; 1968 Dec; 41():169-71. PubMed ID: 4885378
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of fibrous lesions].
    Dankova D
    Bull Int Union Tuberc; 1974; 49(1):306-12. PubMed ID: 4467960
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inoperable bronchial carcinoma complicated by pulmonary tuberculosis: the results of concurrent radiotherapy and anti-tuberculous chemotherapy (author's transl)].
    Broll I; Radenbach KL; Schumacher W
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():609-13. PubMed ID: 461355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.